{
  "first_published_at": "2009-11-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087919", 
  "title": "Oseltamivir (Tamiflu): update to Patient Information Leaflet", 
  "tags": "{\"parsed_therapeutic\": [\"infectious-disease\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Infectious disease\"]}", 
  "_document_number": 234, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "infectious-disease"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Oseltamivir (Tamiflu): update to Patient Information Leaflet</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: November 2009</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We are updating the UK versions of the Patient Information Leaflet for oseltamivir (Tamiflu) to clarify the advice relating to aspirin use during treatment with Tamiflu-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We are updating the UK versions of the Patient Information Leaflet for <strong>oseltamivir (Tamiflu)</strong> to clarify the advice relating to aspirin use during treatment with Tamiflu. The Patient Information Leaflets, including those with the 30/45 mg paediatric formulations, stated that &ldquo;Tamiflu can be taken with paracetamol, ibuprofen, or acetylsalicylic acid (aspirin)&rdquo;. This reflects the fact that there is no known interaction between oseltamivir and aspirin. It must not be interpreted that aspirin can be given to anyone younger than 16 years with Tamiflu. The use of aspirin is, and remains, contraindicated under 16 years because of the risk of Reye&rsquo;s syndrome.</p><p>Further information is available at <a href=\"http://www.mhra.gov.uk/swineflu\" target=\"_blank\">www.mhra.gov.uk/swineflu</a></p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update Nov 2009, vol 3 issue 4: 12a.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We are updating the UK versions of the Patient Information Leaflet for <strong>oseltamivir (Tamiflu)</strong> to clarify the advice relating to aspirin use during treatment with Tamiflu. The Patient Information Leaflets, including those with the 30/45 mg paediatric formulations, stated that &#8220;Tamiflu can be taken with paracetamol, ibuprofen, or acetylsalicylic acid (aspirin)&#8221;. This reflects the fact that there is no known interaction between oseltamivir and aspirin. It must not be interpreted that aspirin can be given to anyone younger than 16 years with Tamiflu. The use of aspirin is, and remains, contraindicated under 16 years because of the risk of Reye&#8217;s syndrome.</p><p>Further information is available at <a href=\"http://www.mhra.gov.uk/swineflu\" target=\"_blank\">www.mhra.gov.uk/swineflu</a></p><p>&#160;</p><p><em>Article citation: Drug Safety Update Nov 2009, vol 3 issue 4: 12a.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2009-11-01", 
  "date_last_modified": "2010-08-17", 
  "_assets": [], 
  "_item_id": 234, 
  "summary": "", 
  "body": "Article date: November 2009\n\nWe are updating the UK versions of the Patient Information Leaflet for oseltamivir (Tamiflu) to clarify the advice relating to aspirin use during treatment with Tamiflu. The Patient Information Leaflets, including those with the 30/45 mg paediatric formulations, stated that “Tamiflu can be taken with paracetamol, ibuprofen, or acetylsalicylic acid (aspirin)”. This reflects the fact that there is no known interaction between oseltamivir and aspirin. It must not be interpreted that aspirin can be given to anyone younger than 16 years with Tamiflu. The use of aspirin is, and remains, contraindicated under 16 years because of the risk of Reye’s syndrome.\n\nFurther information is available at [www.mhra.gov.uk/swineflu](http://www.mhra.gov.uk/swineflu)\n\n \n\nArticle citation: Drug Safety Update Nov 2009, vol 3 issue 4: 12a.\n"
}